CODX Ebit vs Total Revenue Analysis

CODX Stock

USD 0.94 0.01 1.08%

Co Diagnostics financial indicator trend analysis is way more than just evaluating Co Diagnostics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Co Diagnostics is a good investment. Please check the relationship between Co Diagnostics Ebit and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Co Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Ebit vs Total Revenue

Ebit vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Co Diagnostics Ebit account and Total Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between Co Diagnostics' Ebit and Total Revenue is 0.72. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Co Diagnostics, assuming nothing else is changed. The correlation between historical values of Co Diagnostics' Ebit and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Co Diagnostics are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Ebit i.e., Co Diagnostics' Ebit and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.72

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Ebit

Total Revenue

Total revenue comprises all receipts Co Diagnostics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Co Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Co Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Co Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.Selling General Administrative is likely to rise to about 15 M in 2024, despite the fact that Tax Provision is likely to grow to (9.3 M).

Co Diagnostics fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Other Current Liab	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Other Current Assets
Total Assets		0.88	1.0	0.89	0.89	0.69	0.87	1.0	0.84	0.9	0.99	-0.24	0.81	-0.2	0.79	0.6	-0.86	0.89	0.07	-0.17	0.79	0.93	0.94	-0.54	0.86	0.88
Total Current Liabilities	0.88		0.85	0.74	0.77	0.53	0.91	0.84	0.69	0.98	0.86	-0.38	0.65	0.03	0.92	0.48	-0.9	0.81	-0.09	-0.11	0.84	0.76	0.76	-0.57	0.89	0.89
Total Stockholder Equity	1.0	0.85		0.89	0.89	0.7	0.85	1.0	0.84	0.87	0.99	-0.23	0.82	-0.21	0.76	0.61	-0.84	0.88	0.1	-0.17	0.77	0.94	0.95	-0.54	0.83	0.86
Net Tangible Assets	0.89	0.74	0.89		0.71	0.93	0.7	0.89	0.98	0.73	0.88	-0.28	0.97	0.01	0.61	0.88	-0.66	0.92	0.11	-0.21	0.55	0.91	0.93	-0.71	0.66	0.8
Retained Earnings	0.89	0.77	0.89	0.71		0.48	0.85	0.89	0.59	0.82	0.9	0.02	0.6	-0.36	0.78	0.37	-0.84	0.74	0.14	-0.32	0.82	0.69	0.75	-0.19	0.84	0.69
Accounts Payable	0.69	0.53	0.7	0.93	0.48		0.42	0.7	0.94	0.5	0.67	-0.23	0.97	0.23	0.34	0.98	-0.37	0.83	0.11	-0.28	0.23	0.79	0.78	-0.71	0.44	0.62
Cash	0.87	0.91	0.85	0.7	0.85	0.42		0.84	0.61	0.92	0.88	-0.22	0.54	-0.33	0.98	0.33	-1.0	0.72	0.01	0.01	0.97	0.7	0.76	-0.39	0.87	0.86
Cash And Short Term Investments	1.0	0.84	1.0	0.89	0.89	0.7	0.84		0.85	0.86	0.99	-0.25	0.82	-0.2	0.74	0.62	-0.83	0.88	0.13	-0.17	0.76	0.94	0.96	-0.55	0.82	0.85
Capital Surpluse	0.84	0.69	0.84	0.98	0.59	0.94	0.61	0.85		0.68	0.82	-0.38	0.98	0.07	0.52	0.91	-0.57	0.92	0.02	-0.17	0.44	0.9	0.9	-0.8	0.62	0.77
Total Liab	0.9	0.98	0.87	0.73	0.82	0.5	0.92	0.86	0.68		0.87	-0.29	0.64	-0.08	0.93	0.46	-0.9	0.85	-0.2	-0.2	0.84	0.74	0.74	-0.48	0.97	0.89
Total Current Assets	0.99	0.86	0.99	0.88	0.9	0.67	0.88	0.99	0.82	0.87		-0.25	0.78	-0.25	0.79	0.57	-0.88	0.85	0.16	-0.11	0.82	0.92	0.95	-0.53	0.82	0.85
Common Stock	-0.24	-0.38	-0.23	-0.28	0.02	-0.23	-0.22	-0.25	-0.38	-0.29	-0.25		-0.3	-0.3	-0.19	-0.24	0.21	-0.24	-0.05	-0.21	-0.17	-0.32	-0.31	0.72	-0.13	-0.33
Property Plant Equipment	0.81	0.65	0.82	0.97	0.6	0.97	0.54	0.82	0.98	0.64	0.78	-0.3		0.14	0.46	0.95	-0.5	0.93	0.02	-0.31	0.36	0.86	0.86	-0.74	0.6	0.72
Short Long Term Debt Total	-0.2	0.03	-0.21	0.01	-0.36	0.23	-0.33	-0.2	0.07	-0.08	-0.25	-0.3	0.14		-0.25	0.33	0.37	0.03	-0.08	-0.36	-0.45	-0.07	-0.18	-0.41	-0.2	-0.01
Other Current Liab	0.79	0.92	0.76	0.61	0.78	0.34	0.98	0.74	0.52	0.93	0.79	-0.19	0.46	-0.25		0.28	-0.97	0.69	-0.15	-0.05	0.94	0.59	0.63	-0.34	0.89	0.84
Property Plant And Equipment Net	0.6	0.48	0.61	0.88	0.37	0.98	0.33	0.62	0.91	0.46	0.57	-0.24	0.95	0.33	0.28		-0.28	0.82	-0.05	-0.34	0.12	0.73	0.69	-0.72	0.41	0.59
Net Debt	-0.86	-0.9	-0.84	-0.66	-0.84	-0.37	-1.0	-0.83	-0.57	-0.9	-0.88	0.21	-0.5	0.37	-0.97	-0.28		-0.69	-0.02	-0.03	-0.98	-0.69	-0.74	0.36	-0.86	-0.85
Non Current Assets Total	0.89	0.81	0.88	0.92	0.74	0.83	0.72	0.88	0.92	0.85	0.85	-0.24	0.93	0.03	0.69	0.82	-0.69		-0.2	-0.37	0.55	0.83	0.83	-0.63	0.85	0.84
Non Currrent Assets Other	0.07	-0.09	0.1	0.11	0.14	0.11	0.01	0.13	0.02	-0.2	0.16	-0.05	0.02	-0.08	-0.15	-0.05	-0.02	-0.2		0.26	0.1	0.13	0.19	-0.03	-0.33	-0.15
Other Assets	-0.17	-0.11	-0.17	-0.21	-0.32	-0.28	0.01	-0.17	-0.17	-0.2	-0.11	-0.21	-0.31	-0.36	-0.05	-0.34	-0.03	-0.37	0.26		0.12	-0.05	0.0	-0.06	-0.29	-0.2
Net Receivables	0.79	0.84	0.77	0.55	0.82	0.23	0.97	0.76	0.44	0.84	0.82	-0.17	0.36	-0.45	0.94	0.12	-0.98	0.55	0.1	0.12		0.6	0.68	-0.24	0.79	0.75
Common Stock Total Equity	0.93	0.76	0.94	0.91	0.69	0.79	0.7	0.94	0.9	0.74	0.92	-0.32	0.86	-0.07	0.59	0.73	-0.69	0.83	0.13	-0.05	0.6		0.98	-0.68	0.66	0.83
Common Stock Shares Outstanding	0.94	0.76	0.95	0.93	0.75	0.78	0.76	0.96	0.9	0.74	0.95	-0.31	0.86	-0.18	0.63	0.69	-0.74	0.83	0.19	0.0	0.68	0.98		-0.65	0.67	0.8
Long Term Debt Total	-0.54	-0.57	-0.54	-0.71	-0.19	-0.71	-0.39	-0.55	-0.8	-0.48	-0.53	0.72	-0.74	-0.41	-0.34	-0.72	0.36	-0.63	-0.03	-0.06	-0.24	-0.68	-0.65		-0.33	-0.62
Non Current Liabilities Total	0.86	0.89	0.83	0.66	0.84	0.44	0.87	0.82	0.62	0.97	0.82	-0.13	0.6	-0.2	0.89	0.41	-0.86	0.85	-0.33	-0.29	0.79	0.66	0.67	-0.33		0.84
Other Current Assets	0.88	0.89	0.86	0.8	0.69	0.62	0.86	0.85	0.77	0.89	0.85	-0.33	0.72	-0.01	0.84	0.59	-0.85	0.84	-0.15	-0.2	0.75	0.83	0.8	-0.62	0.84

Click cells to compare fundamentals

Co Diagnostics Account Relationship Matchups

Co Diagnostics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.2M	71.2M	160.0M	123.1M	95.3M	50.6M
Total Current Liabilities	328.1K	4.5M	12.6M	3.9M	5.7M	3.8M
Total Stockholder Equity	1.7M	66.7M	134.5M	114.5M	86.0M	44.2M
Net Tangible Assets	1.7M	66.7M	92.6M	87.8M	100.9M	106.0M
Retained Earnings	(25.0M)	17.5M	54.2M	39.9M	4.6M	5.5M
Accounts Payable	6.0K	598.3K	607.5K	952.3K	1.5M	1.6M
Cash	893.1K	43.0M	88.6M	23.0M	14.9M	19.4M
Cash And Short Term Investments	893.1K	47.3M	89.9M	81.3M	58.5M	31.2M
Capital Surpluse	26.7M	49.2M	80.3M	88.5M	101.7M	106.8M
Total Liab	478.1K	4.5M	25.6M	8.6M	9.3M	6.4M
Total Current Assets	1.6M	68.4M	115.1M	92.7M	62.1M	38.2M
Common Stock	17.3K	28.6K	33.8K	34.8K	36.1K	22.9K
Property Plant Equipment	196.8K	949.6K	1.9M	2.5M	2.9M	3.1M
Other Current Liab	320.8K	3.4M	9.6M	1.1M	1.6M	2.2M
Property Plant And Equipment Net	196.8K	949.6K	1.9M	2.9M	6.0M	6.3M
Net Debt	(893.1K)	(43.0M)	(88.6M)	(22.6M)	(11.9M)	(12.5M)
Non Current Assets Total	631.1K	2.9M	44.9M	30.4M	33.2M	34.8M
Non Currrent Assets Other	(631.1K)	1.4M	(484.9K)	672.7K	(1.0)	(0.95)
Net Receivables	131.4K	12.1M	20.9M	5.4M	330.9K	314.3K
Common Stock Total Equity	17.3K	28.6K	33.8K	34.8K	40.0K	21.9K
Common Stock Shares Outstanding	16.8M	28.0M	29.9M	31.5M	29.3M	22.2M
Liabilities And Stockholders Equity	2.2M	71.2M	160.0M	123.1M	95.3M	56.2M
Non Current Liabilities Total	150K	30K	13.0M	4.7M	3.6M	2.8M
Other Current Assets	362.6K	916.3K	2.3M	761.2K	1.6M	889.4K
Other Stockholder Equity	26.7M	49.2M	80.3M	74.3M	81.2M	42.8M
Property Plant And Equipment Gross	196.8K	949.6K	2.6M	4.3M	8.2M	8.6M
Other Liab	150K	30K	13.0M	4.6M	5.3M	3.3M
Retained Earnings Total Equity	(25.0M)	17.5M	54.2M	39.9M	45.9M	48.2M
Inventory	197.2K	8.0M	2.0M	5.3M	1.7M	2.7M
Net Invested Capital	1.7M	66.7M	134.5M	114.5M	86.0M	64.1M
Long Term Investments	434.2K	1.9M	75K	672.7K	773.4K	671.4K
Net Working Capital	1.3M	63.8M	102.5M	88.9M	56.4M	49.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CODX Ebit vs Total Revenue Analysis

Ebit vs Total Revenue

Ebit vs Total Revenue Correlation Analysis

Correlation Coefficient

Ebit

Total Revenue

Co Diagnostics fundamental ratios Correlations

Co Diagnostics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Co Diagnostics fundamental ratios Accounts

Also Currently Popular

Additional Tools for CODX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Cash And Short Term Investments

Net Debt	- 1.0	Cash
Net Receivables	- 0.98	Net Debt
Net Debt	- 0.97	Other Current Liab
Net Debt	- 0.9	Total Liab
Net Debt	- 0.9	Total Current Liabilities
Net Debt	- 0.88	Total Current Assets